Kotak Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Kotak Healthcare Fund - Regular (G)
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹208 Cr | ₹406 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 11 Dec 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | NIFTY Healthcare TRI |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.39 |
| Manager | Rohan Korde | Abhishek Bisen |
| ISIN Code | INF00XX01BL5 | INF174KA1PW4 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Kotak Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | 3.47% | 4.1% |
| 6 Month | 20.7% | 18.54% |
| 1 Year | 43.48% | - |
| 3 Year | 20.61% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 37.03% | - |
| 3 Year | 32% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 20.74% | - |
| 3 Year | 19.19% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 14.52% | - |
| Sharp | - | - |
| Beta | - | - |
| Alpha | - | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Abhishek Bisen |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Fund Manage | 10 | 33 |
| ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.8 | 3.31 |
| Large Cap | 38.11 | 51.29 |
| Mid Cap | 26.43 | 22.8 |
| Small Cap | 33.66 | 24.27 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.8 | 3.31 |
| Pharmaceuticals & Biotechnology | 77 | 79.49 |
| Healthcare Services | 18.01 | 17.64 |
| Chemicals & Petrochemicals | 0.96 | - |
| Fertilizers & Agrochemicals | 1.03 | - |
| Insurance | 1.2 | 1.23 |
Top Comparisons
ICICI Prudential Retirement Fund - Pure Equity - Growth Option
3Y Returns21.52%
HDFC Retirement Savings Fund - Equity Plan - Growth Option
3Y Returns19.74%
HDFC Hybrid Equity Fund - Growth Plan
3Y Returns11.77%
Edelweiss Aggressive Hybrid Fund - Regular Plan - Growth Option
3Y Returns17.15%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns8.69%
Axis NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns0%
Tata Silver Exchange Traded Fund
3Y Returns0%
DSP US Flexible Equity Fund - Regular Plan - Growth
3Y Returns9.98%